

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of gamma-delta T cell activation (GO:0046645) | 6.67847491 |
| 2 | regulation of B cell receptor signaling pathway (GO:0050855) | 5.89816286 |
| 3 | negative regulation of cell killing (GO:0031342) | 5.32886006 |
| 4 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.32886006 |
| 5 | regulation of gamma-delta T cell activation (GO:0046643) | 5.14344305 |
| 6 | fatty acid elongation (GO:0030497) | 5.08066481 |
| 7 | regulation of gamma-delta T cell differentiation (GO:0045586) | 5.01133685 |
| 8 | central nervous system myelination (GO:0022010) | 4.80874714 |
| 9 | axon ensheathment in central nervous system (GO:0032291) | 4.80874714 |
| 10 | L-phenylalanine catabolic process (GO:0006559) | 4.58086406 |
| 11 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.58086406 |
| 12 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.54174409 |
| 13 | B cell receptor signaling pathway (GO:0050853) | 4.49169885 |
| 14 | positive regulation of B cell differentiation (GO:0045579) | 4.38863197 |
| 15 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.32981732 |
| 16 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.29076877 |
| 17 | negative T cell selection (GO:0043383) | 4.24400267 |
| 18 | negative thymic T cell selection (GO:0045060) | 4.14205741 |
| 19 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 4.02595283 |
| 20 | regulation of alpha-beta T cell proliferation (GO:0046640) | 4.02139962 |
| 21 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.99204094 |
| 22 | L-phenylalanine metabolic process (GO:0006558) | 3.94855967 |
| 23 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.94855967 |
| 24 | regulation of B cell differentiation (GO:0045577) | 3.93992113 |
| 25 | T cell migration (GO:0072678) | 3.87891569 |
| 26 | interferon-gamma production (GO:0032609) | 3.82284325 |
| 27 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.80697454 |
| 28 | positive thymic T cell selection (GO:0045059) | 3.76397677 |
| 29 | positive T cell selection (GO:0043368) | 3.74533932 |
| 30 | regulation of regulatory T cell differentiation (GO:0045589) | 3.73178094 |
| 31 | response to interleukin-15 (GO:0070672) | 3.71544136 |
| 32 | negative regulation of T cell mediated immunity (GO:0002710) | 3.70527089 |
| 33 | aromatic amino acid family catabolic process (GO:0009074) | 3.69926448 |
| 34 | cellular response to interleukin-15 (GO:0071350) | 3.65684747 |
| 35 | negative regulation of B cell proliferation (GO:0030889) | 3.62342950 |
| 36 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.61467824 |
| 37 | immunoglobulin mediated immune response (GO:0016064) | 3.61405449 |
| 38 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.57775881 |
| 39 | aldehyde catabolic process (GO:0046185) | 3.54629234 |
| 40 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.51417042 |
| 41 | positive regulation of granulocyte differentiation (GO:0030854) | 3.42107148 |
| 42 | opsonization (GO:0008228) | 3.41033841 |
| 43 | T cell selection (GO:0045058) | 3.38354167 |
| 44 | cholesterol biosynthetic process (GO:0006695) | 3.29879088 |
| 45 | cytidine deamination (GO:0009972) | 3.29036048 |
| 46 | cytidine metabolic process (GO:0046087) | 3.29036048 |
| 47 | cytidine catabolic process (GO:0006216) | 3.29036048 |
| 48 | neutrophil activation involved in immune response (GO:0002283) | 3.26585026 |
| 49 | nucleotide transmembrane transport (GO:1901679) | 3.26281731 |
| 50 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.25914405 |
| 51 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.24731625 |
| 52 | activated T cell proliferation (GO:0050798) | 3.22605137 |
| 53 | negative regulation of interleukin-12 production (GO:0032695) | 3.19885135 |
| 54 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.15777625 |
| 55 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 3.15436259 |
| 56 | B cell mediated immunity (GO:0019724) | 3.15380932 |
| 57 | antigen receptor-mediated signaling pathway (GO:0050851) | 3.13305378 |
| 58 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 3.11537087 |
| 59 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.11454074 |
| 60 | cofactor catabolic process (GO:0051187) | 3.10312177 |
| 61 | negative regulation of T-helper cell differentiation (GO:0045623) | 3.10261325 |
| 62 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 3.10261325 |
| 63 | very long-chain fatty acid metabolic process (GO:0000038) | 3.10067350 |
| 64 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.06780856 |
| 65 | macrophage activation involved in immune response (GO:0002281) | 3.06527469 |
| 66 | bile acid biosynthetic process (GO:0006699) | 3.05786907 |
| 67 | type I interferon signaling pathway (GO:0060337) | 3.05133256 |
| 68 | cellular response to type I interferon (GO:0071357) | 3.05133256 |
| 69 | thymic T cell selection (GO:0045061) | 3.03713480 |
| 70 | response to type I interferon (GO:0034340) | 3.03404445 |
| 71 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.01410546 |
| 72 | negative regulation of adaptive immune response (GO:0002820) | 3.00891940 |
| 73 | amyloid precursor protein catabolic process (GO:0042987) | 3.00353253 |
| 74 | T cell costimulation (GO:0031295) | 2.99363297 |
| 75 | uronic acid metabolic process (GO:0006063) | 2.98555709 |
| 76 | glucuronate metabolic process (GO:0019585) | 2.98555709 |
| 77 | cellular response to ethanol (GO:0071361) | 2.95858864 |
| 78 | lymphocyte costimulation (GO:0031294) | 2.95504295 |
| 79 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.93810341 |
| 80 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.93810341 |
| 81 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.93231402 |
| 82 | tryptophan catabolic process (GO:0006569) | 2.91574436 |
| 83 | indole-containing compound catabolic process (GO:0042436) | 2.91574436 |
| 84 | indolalkylamine catabolic process (GO:0046218) | 2.91574436 |
| 85 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 2.91046422 |
| 86 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.90201934 |
| 87 | sterol biosynthetic process (GO:0016126) | 2.86868047 |
| 88 | amyloid precursor protein metabolic process (GO:0042982) | 2.86493752 |
| 89 | regulation of germinal center formation (GO:0002634) | 2.85320330 |
| 90 | detection of external biotic stimulus (GO:0098581) | 2.83806335 |
| 91 | DNA deamination (GO:0045006) | 2.83179585 |
| 92 | B cell homeostasis (GO:0001782) | 2.83173803 |
| 93 | regulation of T cell receptor signaling pathway (GO:0050856) | 2.81109949 |
| 94 | cellular biogenic amine catabolic process (GO:0042402) | 2.80814519 |
| 95 | amine catabolic process (GO:0009310) | 2.80814519 |
| 96 | T cell receptor signaling pathway (GO:0050852) | 2.80460571 |
| 97 | positive regulation of B cell mediated immunity (GO:0002714) | 2.80228514 |
| 98 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 2.80228514 |
| 99 | long-chain fatty-acyl-CoA metabolic process (GO:0035336) | 2.79965869 |
| 100 | leukocyte aggregation (GO:0070486) | 2.79886485 |
| 101 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 2.79850162 |
| 102 | negative regulation of alpha-beta T cell activation (GO:0046636) | 2.79080218 |
| 103 | protein carboxylation (GO:0018214) | 2.78899361 |
| 104 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.78899361 |
| 105 | cholesterol efflux (GO:0033344) | 2.77887938 |
| 106 | histamine secretion (GO:0001821) | 2.77588389 |
| 107 | regulation of T cell tolerance induction (GO:0002664) | 2.76524956 |
| 108 | positive regulation of defense response to virus by host (GO:0002230) | 2.76271926 |
| 109 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.75854068 |
| 110 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 2.75533108 |
| 111 | regulation of cholesterol esterification (GO:0010872) | 2.74924136 |
| 112 | fatty-acyl-CoA metabolic process (GO:0035337) | 2.74745774 |
| 113 | B cell proliferation (GO:0042100) | 2.74421562 |
| 114 | long-chain fatty acid biosynthetic process (GO:0042759) | 2.74227314 |
| 115 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 2.74047505 |
| 116 | tolerance induction (GO:0002507) | 2.74007068 |
| 117 | regulation of B cell proliferation (GO:0030888) | 2.73753385 |
| 118 | myeloid cell activation involved in immune response (GO:0002275) | 2.73641765 |
| 119 | positive regulation of humoral immune response (GO:0002922) | 2.73420663 |
| 120 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 2.72922733 |
| 121 | regulation of alpha-beta T cell activation (GO:0046634) | 2.72648005 |
| 122 | fibrinolysis (GO:0042730) | 2.72518978 |
| 123 | tryptophan metabolic process (GO:0006568) | 2.72130228 |
| 124 | detection of molecule of bacterial origin (GO:0032490) | 2.71560106 |
| 125 | plasma lipoprotein particle clearance (GO:0034381) | 2.71268125 |
| 126 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 2.70941347 |
| 127 | mast cell activation (GO:0045576) | 2.70890008 |
| 128 | regulation of antigen processing and presentation (GO:0002577) | 2.70653270 |
| 129 | regulation of CD4-positive, alpha-beta T cell activation (GO:2000514) | 2.70358381 |
| 130 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.70317469 |
| 131 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.70229648 |
| 132 | high-density lipoprotein particle remodeling (GO:0034375) | 2.70149252 |
| 133 | negative regulation of type 2 immune response (GO:0002829) | 2.68766615 |
| 134 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.68360881 |
| 135 | cellular glucuronidation (GO:0052695) | 2.66599178 |
| 136 | glyoxylate metabolic process (GO:0046487) | 2.62640910 |
| 137 | coenzyme catabolic process (GO:0009109) | 2.62295225 |
| 138 | signal peptide processing (GO:0006465) | 2.59846896 |
| 139 | low-density lipoprotein particle remodeling (GO:0034374) | 2.57255442 |
| 140 | complement activation, alternative pathway (GO:0006957) | 2.55834663 |
| 141 | respiratory burst (GO:0045730) | 2.54483787 |
| 142 | phospholipid efflux (GO:0033700) | 2.53423644 |
| 143 | very-low-density lipoprotein particle assembly (GO:0034379) | 2.52058953 |
| 144 | regulation of fibrinolysis (GO:0051917) | 2.52050444 |
| 145 | protein neddylation (GO:0045116) | 2.51414672 |
| 146 | bile acid metabolic process (GO:0008206) | 2.51338932 |
| 147 | negative regulation of neurotransmitter secretion (GO:0046929) | 2.51018538 |
| 148 | isoprenoid biosynthetic process (GO:0008299) | 2.50323147 |
| 149 | positive regulation of cellular amine metabolic process (GO:0033240) | 2.50194656 |
| 150 | regulation of triglyceride catabolic process (GO:0010896) | 2.49848032 |
| 151 | response to nitrosative stress (GO:0051409) | 2.49480705 |
| 152 | cysteine metabolic process (GO:0006534) | 2.48808436 |
| 153 | intracellular pH reduction (GO:0051452) | 2.46600524 |
| 154 | aromatic amino acid family metabolic process (GO:0009072) | 2.44977971 |
| 155 | protein-lipid complex remodeling (GO:0034368) | 2.44951250 |
| 156 | macromolecular complex remodeling (GO:0034367) | 2.44951250 |
| 157 | plasma lipoprotein particle remodeling (GO:0034369) | 2.44951250 |
| 158 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.44511766 |
| 159 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.44511766 |
| 160 | modulation by symbiont of host immune response (GO:0052553) | 2.44511766 |
| 161 | positive regulation by symbiont of host defense response (GO:0052509) | 2.44511766 |
| 162 | modulation by symbiont of host defense response (GO:0052031) | 2.44511766 |
| 163 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.44511766 |
| 164 | sulfur amino acid catabolic process (GO:0000098) | 2.42709195 |
| 165 | glutathione derivative metabolic process (GO:1901685) | 2.42579031 |
| 166 | glutathione derivative biosynthetic process (GO:1901687) | 2.42579031 |
| 167 | positive regulation of interleukin-1 beta secretion (GO:0050718) | 2.41489220 |
| 168 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 2.40940840 |
| 169 | alpha-linolenic acid metabolic process (GO:0036109) | 2.40841314 |
| 170 | reverse cholesterol transport (GO:0043691) | 2.38826482 |
| 171 | regulation of interleukin-1 beta secretion (GO:0050706) | 2.37588651 |
| 172 | heme transport (GO:0015886) | 2.37303231 |
| 173 | tyrosine metabolic process (GO:0006570) | 2.36755106 |
| 174 | detection of other organism (GO:0098543) | 2.36629327 |
| 175 | positive regulation of interferon-alpha production (GO:0032727) | 2.36478914 |
| 176 | regulation of collateral sprouting (GO:0048670) | 2.35786529 |
| 177 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.35031672 |
| 178 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.34968372 |
| 179 | kynurenine metabolic process (GO:0070189) | 2.34165627 |
| 180 | import into cell (GO:0098657) | 2.33914410 |
| 181 | regulation of protein activation cascade (GO:2000257) | 2.32472215 |
| 182 | acyl-CoA metabolic process (GO:0006637) | 2.32087413 |
| 183 | thioester metabolic process (GO:0035383) | 2.32087413 |
| 184 | cellular response to exogenous dsRNA (GO:0071360) | 2.31849828 |
| 185 | microglial cell activation (GO:0001774) | 2.31713545 |
| 186 | negative regulation of neurotransmitter transport (GO:0051589) | 2.30808033 |
| 187 | thioester biosynthetic process (GO:0035384) | 2.29951608 |
| 188 | acyl-CoA biosynthetic process (GO:0071616) | 2.29951608 |
| 189 | regulation of lipoprotein metabolic process (GO:0050746) | 2.28895517 |
| 190 | detection of bacterium (GO:0016045) | 2.28791068 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 4.05570493 |
| 2 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 3.66909083 |
| 3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.47437968 |
| 4 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.38184066 |
| 5 | GATA1_22025678_ChIP-Seq_K562_Human | 3.00200052 |
| 6 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.93279820 |
| 7 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.84743975 |
| 8 | MYB_26560356_Chip-Seq_TH2_Human | 2.81155059 |
| 9 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.71822844 |
| 10 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.66807294 |
| 11 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.63996828 |
| 12 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.62094594 |
| 13 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.48336291 |
| 14 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.36438475 |
| 15 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.32415839 |
| 16 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.23006427 |
| 17 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.18285859 |
| 18 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.18178975 |
| 19 | MYB_26560356_Chip-Seq_TH1_Human | 2.16878967 |
| 20 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 2.16822383 |
| 21 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.15894328 |
| 22 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.11356583 |
| 23 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.10189745 |
| 24 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 2.05376603 |
| 25 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.04944735 |
| 26 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.01027532 |
| 27 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.96552688 |
| 28 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.94925630 |
| 29 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.93220305 |
| 30 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.91701034 |
| 31 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.91477572 |
| 32 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.89829293 |
| 33 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.86435822 |
| 34 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.86153517 |
| 35 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.84651305 |
| 36 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.82630997 |
| 37 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.81913909 |
| 38 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.81913909 |
| 39 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.81373393 |
| 40 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.71889871 |
| 41 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.69265162 |
| 42 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.67938898 |
| 43 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.65439216 |
| 44 | P300_19829295_ChIP-Seq_ESCs_Human | 1.58528280 |
| 45 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.52212140 |
| 46 | * ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.50838160 |
| 47 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.50532279 |
| 48 | MAF_26560356_Chip-Seq_TH1_Human | 1.49095326 |
| 49 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.47879412 |
| 50 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.46852205 |
| 51 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.44413510 |
| 52 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.44035263 |
| 53 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.43262290 |
| 54 | VDR_22108803_ChIP-Seq_LS180_Human | 1.39686976 |
| 55 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.37865835 |
| 56 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.37682801 |
| 57 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.36836267 |
| 58 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.36341711 |
| 59 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.36321362 |
| 60 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.35098814 |
| 61 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.31607135 |
| 62 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.30442665 |
| 63 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.25968213 |
| 64 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.24741584 |
| 65 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.24551197 |
| 66 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.22631163 |
| 67 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.22201361 |
| 68 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.21402468 |
| 69 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.20083910 |
| 70 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.19891675 |
| 71 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.19488681 |
| 72 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.18798033 |
| 73 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.18740935 |
| 74 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.18654971 |
| 75 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.18618110 |
| 76 | SPI1_23127762_ChIP-Seq_K562_Human | 1.18468995 |
| 77 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.14967836 |
| 78 | UTX_26944678_Chip-Seq_JUKART_Human | 1.12640197 |
| 79 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.12190239 |
| 80 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.11265602 |
| 81 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.10794359 |
| 82 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.10701108 |
| 83 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.10517464 |
| 84 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.08788123 |
| 85 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.08484225 |
| 86 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.08418200 |
| 87 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.08411483 |
| 88 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.08286605 |
| 89 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.08193330 |
| 90 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.08091312 |
| 91 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.07875033 |
| 92 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.07192944 |
| 93 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.06458252 |
| 94 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.06187079 |
| 95 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.05999505 |
| 96 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 1.05991072 |
| 97 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.05914239 |
| 98 | P300_18555785_Chip-Seq_ESCs_Mouse | 1.05713501 |
| 99 | GATA3_26560356_Chip-Seq_TH1_Human | 1.04335618 |
| 100 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.03695128 |
| 101 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.03337161 |
| 102 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.03103829 |
| 103 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.02718623 |
| 104 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.02635725 |
| 105 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.02536235 |
| 106 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.02139581 |
| 107 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.01873367 |
| 108 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.01857725 |
| 109 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.01311591 |
| 110 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 1.00826241 |
| 111 | SMRT_27268052_Chip-Seq_Bcells_Human | 1.00147194 |
| 112 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.00142408 |
| 113 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.99775791 |
| 114 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.99775791 |
| 115 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 0.99760478 |
| 116 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 0.99285297 |
| 117 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.99284464 |
| 118 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.98580010 |
| 119 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.97003720 |
| 120 | * SMAD1_18555785_Chip-Seq_ESCs_Mouse | 0.96928473 |
| 121 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 0.96912505 |
| 122 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 0.96566141 |
| 123 | FUS_26573619_Chip-Seq_HEK293_Human | 0.96518346 |
| 124 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.96270434 |
| 125 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.95830476 |
| 126 | GATA3_26560356_Chip-Seq_TH2_Human | 0.94211525 |
| 127 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.94140165 |
| 128 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.93785598 |
| 129 | EWS_26573619_Chip-Seq_HEK293_Human | 0.93695700 |
| 130 | PU1_27457419_Chip-Seq_LIVER_Mouse | 0.93343076 |
| 131 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.93182728 |
| 132 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 0.93037832 |
| 133 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 0.92841365 |
| 134 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.92513879 |
| 135 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.92373872 |
| 136 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.91957727 |
| 137 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 0.90848195 |
| 138 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.90536435 |
| 139 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.90139998 |
| 140 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 0.89529975 |
| 141 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.89205405 |
| 142 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 0.88926320 |
| 143 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.88121485 |
| 144 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.87842386 |
| 145 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.87145592 |
| 146 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.87097007 |
| 147 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.83718161 |
| 148 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.83506187 |
| 149 | MYC_22102868_ChIP-Seq_BL_Human | 0.83050640 |
| 150 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 0.82622810 |
| 151 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.80395201 |
| 152 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.80034741 |
| 153 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.79603749 |
| 154 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.78865468 |
| 155 | MAF_26560356_Chip-Seq_TH2_Human | 0.78020718 |
| 156 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 0.77812520 |
| 157 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.77154094 |
| 158 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.75813582 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 3.65040736 |
| 2 | MP0005360_urolithiasis | 3.56267272 |
| 3 | MP0008875_abnormal_xenobiotic_pharmacok | 3.56208413 |
| 4 | MP0003763_abnormal_thymus_physiology | 3.37728691 |
| 5 | MP0003724_increased_susceptibility_to | 3.32627415 |
| 6 | MP0005085_abnormal_gallbladder_physiolo | 3.18589300 |
| 7 | MP0002166_altered_tumor_susceptibility | 2.89263673 |
| 8 | MP0001835_abnormal_antigen_presentation | 2.72856703 |
| 9 | MP0003806_abnormal_nucleotide_metabolis | 2.63505227 |
| 10 | MP0009785_altered_susceptibility_to | 2.58926772 |
| 11 | MP0005365_abnormal_bile_salt | 2.57999128 |
| 12 | MP0000920_abnormal_myelination | 2.43973364 |
| 13 | MP0003690_abnormal_glial_cell | 2.43521319 |
| 14 | MP0006082_CNS_inflammation | 2.35578828 |
| 15 | MP0002006_tumorigenesis | 2.16713827 |
| 16 | MP0002009_preneoplasia | 2.16536871 |
| 17 | MP0005671_abnormal_response_to | 2.14510272 |
| 18 | MP0000604_amyloidosis | 2.07553308 |
| 19 | MP0002398_abnormal_bone_marrow | 2.07295833 |
| 20 | MP0002419_abnormal_innate_immunity | 2.04430599 |
| 21 | MP0003195_calcinosis | 2.02170292 |
| 22 | MP0002148_abnormal_hypersensitivity_rea | 1.97335457 |
| 23 | MP0009840_abnormal_foam_cell | 1.90737138 |
| 24 | MP0005058_abnormal_lysosome_morphology | 1.88519612 |
| 25 | MP0002132_abnormal_respiratory_system | 1.87980923 |
| 26 | MP0005025_abnormal_response_to | 1.87891359 |
| 27 | MP0003191_abnormal_cellular_cholesterol | 1.87539813 |
| 28 | MP0004147_increased_porphyrin_level | 1.87314749 |
| 29 | MP0000569_abnormal_digit_pigmentation | 1.86030066 |
| 30 | MP0005000_abnormal_immune_tolerance | 1.85639238 |
| 31 | MP0000689_abnormal_spleen_morphology | 1.84198424 |
| 32 | MP0009764_decreased_sensitivity_to | 1.83844718 |
| 33 | MP0008057_abnormal_DNA_replication | 1.83050034 |
| 34 | MP0003186_abnormal_redox_activity | 1.81324019 |
| 35 | MP0001790_abnormal_immune_system | 1.79494866 |
| 36 | MP0005387_immune_system_phenotype | 1.79494866 |
| 37 | MP0005075_abnormal_melanosome_morpholog | 1.79402237 |
| 38 | MP0003436_decreased_susceptibility_to | 1.75367082 |
| 39 | MP0010329_abnormal_lipoprotein_level | 1.73127151 |
| 40 | MP0003880_abnormal_central_pattern | 1.73027045 |
| 41 | MP0002722_abnormal_immune_system | 1.71238979 |
| 42 | MP0003300_gastrointestinal_ulcer | 1.69650426 |
| 43 | MP0009697_abnormal_copulation | 1.67651949 |
| 44 | MP0002396_abnormal_hematopoietic_system | 1.63877521 |
| 45 | MP0000703_abnormal_thymus_morphology | 1.61519737 |
| 46 | MP0002876_abnormal_thyroid_physiology | 1.60018717 |
| 47 | MP0003656_abnormal_erythrocyte_physiolo | 1.57262710 |
| 48 | MP0001873_stomach_inflammation | 1.57069294 |
| 49 | MP0005083_abnormal_biliary_tract | 1.56248905 |
| 50 | MP0002429_abnormal_blood_cell | 1.54473404 |
| 51 | MP0003866_abnormal_defecation | 1.52765906 |
| 52 | MP0005332_abnormal_amino_acid | 1.51204026 |
| 53 | MP0005451_abnormal_body_composition | 1.49634330 |
| 54 | MP0001666_abnormal_nutrient_absorption | 1.48578756 |
| 55 | MP0006054_spinal_hemorrhage | 1.47272592 |
| 56 | MP0002723_abnormal_immune_serum | 1.43400521 |
| 57 | MP0008469_abnormal_protein_level | 1.42737306 |
| 58 | MP0002452_abnormal_antigen_presenting | 1.40793497 |
| 59 | MP0004782_abnormal_surfactant_physiolog | 1.39717902 |
| 60 | MP0001800_abnormal_humoral_immune | 1.38794388 |
| 61 | MP0008260_abnormal_autophagy | 1.33897957 |
| 62 | MP0004381_abnormal_hair_follicle | 1.33101010 |
| 63 | MP0005464_abnormal_platelet_physiology | 1.30551725 |
| 64 | MP0000685_abnormal_immune_system | 1.29829597 |
| 65 | MP0003075_altered_response_to | 1.29481367 |
| 66 | MP0002254_reproductive_system_inflammat | 1.29099728 |
| 67 | MP0003950_abnormal_plasma_membrane | 1.28268885 |
| 68 | MP0005408_hypopigmentation | 1.27073210 |
| 69 | MP0001533_abnormal_skeleton_physiology | 1.26342423 |
| 70 | MP0001764_abnormal_homeostasis | 1.25803585 |
| 71 | MP0002118_abnormal_lipid_homeostasis | 1.24684887 |
| 72 | MP0001905_abnormal_dopamine_level | 1.21608244 |
| 73 | MP0003329_amyloid_beta_deposits | 1.20494428 |
| 74 | MP0005166_decreased_susceptibility_to | 1.18022482 |
| 75 | MP0002420_abnormal_adaptive_immunity | 1.17530250 |
| 76 | MP0003183_abnormal_peptide_metabolism | 1.17199860 |
| 77 | MP0001819_abnormal_immune_cell | 1.16300089 |
| 78 | MP0005164_abnormal_response_to | 1.16108165 |
| 79 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.14137214 |
| 80 | MP0004947_skin_inflammation | 1.12205722 |
| 81 | MP0002405_respiratory_system_inflammati | 1.11808283 |
| 82 | MP0001851_eye_inflammation | 1.11721236 |
| 83 | MP0001845_abnormal_inflammatory_respons | 1.08750710 |
| 84 | MP0004019_abnormal_vitamin_homeostasis | 1.08678327 |
| 85 | MP0009763_increased_sensitivity_to | 1.05805814 |
| 86 | MP0000609_abnormal_liver_physiology | 1.01720033 |
| 87 | MP0003136_yellow_coat_color | 0.97500864 |
| 88 | MP0009765_abnormal_xenobiotic_induced | 0.95179447 |
| 89 | MP0009379_abnormal_foot_pigmentation | 0.93859566 |
| 90 | MP0003252_abnormal_bile_duct | 0.92413666 |
| 91 | MP0001529_abnormal_vocalization | 0.91841253 |
| 92 | MP0000015_abnormal_ear_pigmentation | 0.91489392 |
| 93 | MP0000858_altered_metastatic_potential | 0.91455854 |
| 94 | MP0002138_abnormal_hepatobiliary_system | 0.89112032 |
| 95 | MP0005319_abnormal_enzyme/_coenzyme | 0.88805345 |
| 96 | MP0010155_abnormal_intestine_physiology | 0.88241640 |
| 97 | MP0003172_abnormal_lysosome_physiology | 0.88196053 |
| 98 | MP0003786_premature_aging | 0.87392857 |
| 99 | MP0002019_abnormal_tumor_incidence | 0.86231328 |
| 100 | MP0003045_fibrosis | 0.85805069 |
| 101 | MP0003011_delayed_dark_adaptation | 0.85531888 |
| 102 | MP0003303_peritoneal_inflammation | 0.80493682 |
| 103 | MP0004808_abnormal_hematopoietic_stem | 0.79463948 |
| 104 | MP0001542_abnormal_bone_strength | 0.78932537 |
| 105 | MP0009333_abnormal_splenocyte_physiolog | 0.76460024 |
| 106 | MP0010307_abnormal_tumor_latency | 0.75567215 |
| 107 | MP0001501_abnormal_sleep_pattern | 0.75544529 |
| 108 | MP0000716_abnormal_immune_system | 0.75143155 |
| 109 | MP0004883_abnormal_blood_vessel | 0.74842900 |
| 110 | MP0003633_abnormal_nervous_system | 0.74722104 |
| 111 | MP0009643_abnormal_urine_homeostasis | 0.74596471 |
| 112 | MP0003448_altered_tumor_morphology | 0.74508196 |
| 113 | MP0002136_abnormal_kidney_physiology | 0.73623246 |
| 114 | MP0002277_abnormal_respiratory_mucosa | 0.73215852 |
| 115 | MP0005379_endocrine/exocrine_gland_phen | 0.72051779 |
| 116 | MP0004742_abnormal_vestibular_system | 0.71883839 |
| 117 | MP0000343_altered_response_to | 0.71399152 |
| 118 | MP0002933_joint_inflammation | 0.71103941 |
| 119 | MP0000465_gastrointestinal_hemorrhage | 0.70066655 |
| 120 | MP0003718_maternal_effect | 0.69920126 |
| 121 | MP0001853_heart_inflammation | 0.69638545 |
| 122 | MP0005636_abnormal_mineral_homeostasis | 0.69323471 |
| 123 | MP0000427_abnormal_hair_cycle | 0.68805795 |
| 124 | MP0003221_abnormal_cardiomyocyte_apopto | 0.68652974 |
| 125 | MP0003828_pulmonary_edema | 0.68486198 |
| 126 | MP0003868_abnormal_feces_composition | 0.68427691 |
| 127 | MP0005310_abnormal_salivary_gland | 0.68252525 |
| 128 | MP0005376_homeostasis/metabolism_phenot | 0.67445781 |
| 129 | MP0010234_abnormal_vibrissa_follicle | 0.67426083 |
| 130 | MP0002693_abnormal_pancreas_physiology | 0.67370790 |
| 131 | MP0002998_abnormal_bone_remodeling | 0.64646662 |
| 132 | MP0000371_diluted_coat_color | 0.64557294 |
| 133 | MP0008004_abnormal_stomach_pH | 0.62396150 |
| 134 | MP0002064_seizures | 0.62227367 |
| 135 | MP0000372_irregular_coat_pigmentation | 0.60869583 |
| 136 | MP0000249_abnormal_blood_vessel | 0.59888310 |
| 137 | MP0001661_extended_life_span | 0.59622189 |
| 138 | MP0010094_abnormal_chromosome_stability | 0.59414926 |
| 139 | MP0006035_abnormal_mitochondrial_morpho | 0.58386730 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | T lymphocytopenia (HP:0005403) | 4.52465928 |
| 2 | Intrahepatic cholestasis (HP:0001406) | 4.16035788 |
| 3 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.14913110 |
| 4 | Prolonged partial thromboplastin time (HP:0003645) | 3.99083067 |
| 5 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.89245730 |
| 6 | Recurrent fungal infections (HP:0002841) | 3.82941627 |
| 7 | Panhypogammaglobulinemia (HP:0003139) | 3.82548457 |
| 8 | Recurrent viral infections (HP:0004429) | 3.81137015 |
| 9 | Meningitis (HP:0001287) | 3.78514065 |
| 10 | IgM deficiency (HP:0002850) | 3.77971519 |
| 11 | Abnormality of T cells (HP:0002843) | 3.72415955 |
| 12 | Parakeratosis (HP:0001036) | 3.69571703 |
| 13 | IgG deficiency (HP:0004315) | 3.67258005 |
| 14 | Recurrent bronchitis (HP:0002837) | 3.62224830 |
| 15 | Recurrent cutaneous fungal infections (HP:0011370) | 3.58113186 |
| 16 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.58113186 |
| 17 | Agammaglobulinemia (HP:0004432) | 3.57998579 |
| 18 | Abnormality of B cell number (HP:0010975) | 3.51463785 |
| 19 | Mediastinal lymphadenopathy (HP:0100721) | 3.43832849 |
| 20 | Chronic diarrhea (HP:0002028) | 3.39750907 |
| 21 | Autoimmune thrombocytopenia (HP:0001973) | 3.37494375 |
| 22 | Abnormality of the prostate (HP:0008775) | 3.36416804 |
| 23 | Xanthomatosis (HP:0000991) | 3.31928898 |
| 24 | B lymphocytopenia (HP:0010976) | 3.29307070 |
| 25 | Encephalitis (HP:0002383) | 3.24029456 |
| 26 | Severe combined immunodeficiency (HP:0004430) | 3.21285685 |
| 27 | Abnormality of T cell physiology (HP:0011840) | 3.21132719 |
| 28 | Neurofibrillary tangles (HP:0002185) | 3.19738218 |
| 29 | Hypobetalipoproteinemia (HP:0003563) | 3.19628082 |
| 30 | Hyperlipoproteinemia (HP:0010980) | 3.18195055 |
| 31 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.13387690 |
| 32 | Vacuolated lymphocytes (HP:0001922) | 3.11215141 |
| 33 | Gastrointestinal infarctions (HP:0005244) | 3.08148405 |
| 34 | Deep venous thrombosis (HP:0002625) | 3.07980141 |
| 35 | Recurrent sinusitis (HP:0011108) | 3.05484036 |
| 36 | Lymphopenia (HP:0001888) | 3.02808476 |
| 37 | IgA deficiency (HP:0002720) | 2.99976277 |
| 38 | Thyroiditis (HP:0100646) | 2.99940110 |
| 39 | Pulmonary infiltrates (HP:0002113) | 2.91548989 |
| 40 | Joint hemorrhage (HP:0005261) | 2.89000505 |
| 41 | Recurrent abscess formation (HP:0002722) | 2.87689674 |
| 42 | Pustule (HP:0200039) | 2.86518205 |
| 43 | Conjugated hyperbilirubinemia (HP:0002908) | 2.86123433 |
| 44 | Abnormality of macrophages (HP:0004311) | 2.85402272 |
| 45 | Hemoptysis (HP:0002105) | 2.82830189 |
| 46 | Renal Fanconi syndrome (HP:0001994) | 2.82666840 |
| 47 | Hepatosplenomegaly (HP:0001433) | 2.82462109 |
| 48 | Fat malabsorption (HP:0002630) | 2.81080603 |
| 49 | Recurrent bacterial skin infections (HP:0005406) | 2.80278887 |
| 50 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.80183064 |
| 51 | Complement deficiency (HP:0004431) | 2.76490049 |
| 52 | Combined immunodeficiency (HP:0005387) | 2.75541551 |
| 53 | Eosinophilia (HP:0001880) | 2.75379352 |
| 54 | Acanthocytosis (HP:0001927) | 2.74945100 |
| 55 | Steatorrhea (HP:0002570) | 2.72514760 |
| 56 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.70476639 |
| 57 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.70476639 |
| 58 | Colitis (HP:0002583) | 2.69026243 |
| 59 | Granulocytopenia (HP:0001913) | 2.67090167 |
| 60 | Stomatitis (HP:0010280) | 2.66414868 |
| 61 | Systemic lupus erythematosus (HP:0002725) | 2.61798704 |
| 62 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 2.60815776 |
| 63 | Gastrointestinal stroma tumor (HP:0100723) | 2.60417075 |
| 64 | Eczematoid dermatitis (HP:0000976) | 2.59164524 |
| 65 | Chronic obstructive pulmonary disease (HP:0006510) | 2.58333174 |
| 66 | Obstructive lung disease (HP:0006536) | 2.58333174 |
| 67 | Inflammation of the large intestine (HP:0002037) | 2.57654039 |
| 68 | Abnormality of eosinophils (HP:0001879) | 2.56929639 |
| 69 | Axonal loss (HP:0003447) | 2.52089567 |
| 70 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.46118290 |
| 71 | Increased serum pyruvate (HP:0003542) | 2.44094211 |
| 72 | Abnormality of glycolysis (HP:0004366) | 2.44094211 |
| 73 | Leukocytosis (HP:0001974) | 2.42926419 |
| 74 | Chest pain (HP:0100749) | 2.42326580 |
| 75 | Spontaneous abortion (HP:0005268) | 2.41482525 |
| 76 | Hematochezia (HP:0002573) | 2.39083516 |
| 77 | Lymphoma (HP:0002665) | 2.36446856 |
| 78 | Purpura (HP:0000979) | 2.35201906 |
| 79 | Bronchitis (HP:0012387) | 2.34296720 |
| 80 | Congenital ichthyosiform erythroderma (HP:0007431) | 2.32588335 |
| 81 | Gastrointestinal inflammation (HP:0004386) | 2.32049324 |
| 82 | Acute encephalopathy (HP:0006846) | 2.30071668 |
| 83 | Abnormality of methionine metabolism (HP:0010901) | 2.28982502 |
| 84 | Abnormality of the common coagulation pathway (HP:0010990) | 2.27264730 |
| 85 | Acute necrotizing encephalopathy (HP:0006965) | 2.27042806 |
| 86 | Sensory axonal neuropathy (HP:0003390) | 2.26991096 |
| 87 | Amyloidosis (HP:0011034) | 2.26638935 |
| 88 | Spontaneous hematomas (HP:0007420) | 2.26484311 |
| 89 | Increased hepatocellular lipid droplets (HP:0006565) | 2.25713010 |
| 90 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.25173764 |
| 91 | Cerebral hemorrhage (HP:0001342) | 2.24871736 |
| 92 | Prostate neoplasm (HP:0100787) | 2.24048949 |
| 93 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.23669151 |
| 94 | Viral hepatitis (HP:0006562) | 2.23116876 |
| 95 | Arterial thrombosis (HP:0004420) | 2.21978813 |
| 96 | Glomerulonephritis (HP:0000099) | 2.21505721 |
| 97 | Lipid accumulation in hepatocytes (HP:0006561) | 2.20387764 |
| 98 | Abnormality of renal resorption (HP:0011038) | 2.20123858 |
| 99 | Recurrent pneumonia (HP:0006532) | 2.19923074 |
| 100 | Cellulitis (HP:0100658) | 2.18860067 |
| 101 | Hypoproteinemia (HP:0003075) | 2.18738497 |
| 102 | Osteomyelitis (HP:0002754) | 2.18666865 |
| 103 | Recurrent skin infections (HP:0001581) | 2.18376578 |
| 104 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.16916583 |
| 105 | Verrucae (HP:0200043) | 2.16788975 |
| 106 | Papilloma (HP:0012740) | 2.16788975 |
| 107 | Fair hair (HP:0002286) | 2.16709827 |
| 108 | Cerebral edema (HP:0002181) | 2.15838550 |
| 109 | Increased IgE level (HP:0003212) | 2.15257489 |
| 110 | Abnormality of complement system (HP:0005339) | 2.12692170 |
| 111 | Mitochondrial inheritance (HP:0001427) | 2.11016394 |
| 112 | Gingival bleeding (HP:0000225) | 2.10799356 |
| 113 | Abnormality of the pleura (HP:0002103) | 2.09909408 |
| 114 | Fatigue (HP:0012378) | 2.09862933 |
| 115 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.09595827 |
| 116 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.09595827 |
| 117 | Abnormality of glycolipid metabolism (HP:0010969) | 2.09595827 |
| 118 | Autoamputation (HP:0001218) | 2.08455594 |
| 119 | Acute hepatic failure (HP:0006554) | 2.06735157 |
| 120 | Gingivitis (HP:0000230) | 2.05937371 |
| 121 | Anorexia (HP:0002039) | 2.05814767 |
| 122 | Urticaria (HP:0001025) | 2.05033964 |
| 123 | Epidermoid cyst (HP:0200040) | 2.04231605 |
| 124 | Cerebral inclusion bodies (HP:0100314) | 2.03762699 |
| 125 | Skin rash (HP:0000988) | 2.02529927 |
| 126 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.02521565 |
| 127 | Abnormality of male internal genitalia (HP:0000022) | 2.01794483 |
| 128 | Retrobulbar optic neuritis (HP:0100654) | 2.00940141 |
| 129 | Optic neuritis (HP:0100653) | 2.00940141 |
| 130 | Hypolipoproteinemia (HP:0010981) | 2.00870135 |
| 131 | Chronic otitis media (HP:0000389) | 1.98437095 |
| 132 | Hypophosphatemic rickets (HP:0004912) | 1.97435266 |
| 133 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 1.94939328 |
| 134 | Keratoconjunctivitis sicca (HP:0001097) | 1.94764851 |
| 135 | Recurrent lower respiratory tract infections (HP:0002783) | 1.94695001 |
| 136 | Bronchiectasis (HP:0002110) | 1.92985268 |
| 137 | Prolonged neonatal jaundice (HP:0006579) | 1.91110810 |
| 138 | Abnormal mitochondria in muscle tissue (HP:0008316) | 1.90768251 |
| 139 | Hypercholesterolemia (HP:0003124) | 1.89745101 |
| 140 | Joint swelling (HP:0001386) | 1.89395883 |
| 141 | Pulmonary embolism (HP:0002204) | 1.87841803 |
| 142 | Polyneuropathy (HP:0001271) | 1.87580557 |
| 143 | Spastic paraparesis (HP:0002313) | 1.87027138 |
| 144 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.86447675 |
| 145 | Keratoconjunctivitis (HP:0001096) | 1.86353127 |
| 146 | Orchitis (HP:0100796) | 1.85661762 |
| 147 | Hypoplasia of the thymus (HP:0000778) | 1.85468401 |
| 148 | Vasculitis (HP:0002633) | 1.85070696 |
| 149 | Abnormality of urine glucose concentration (HP:0011016) | 1.84267923 |
| 150 | Glycosuria (HP:0003076) | 1.84267923 |
| 151 | 3-Methylglutaconic aciduria (HP:0003535) | 1.84141625 |
| 152 | Amaurosis fugax (HP:0100576) | 1.84121106 |
| 153 | Slow saccadic eye movements (HP:0000514) | 1.84031140 |
| 154 | Progressive macrocephaly (HP:0004481) | 1.83818723 |
| 155 | Keratitis (HP:0000491) | 1.83659817 |
| 156 | Increased CSF lactate (HP:0002490) | 1.83441324 |
| 157 | Basal cell carcinoma (HP:0002671) | 1.82956692 |
| 158 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.82068501 |
| 159 | Premature loss of primary teeth (HP:0006323) | 1.81281418 |
| 160 | Increased cerebral lipofuscin (HP:0011813) | 1.81195594 |
| 161 | Leukodystrophy (HP:0002415) | 1.81125920 |
| 162 | Gangrene (HP:0100758) | 1.80500480 |
| 163 | Autoimmune hemolytic anemia (HP:0001890) | 1.80414169 |
| 164 | Vascular calcification (HP:0004934) | 1.78488857 |
| 165 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.77918740 |
| 166 | Hepatocellular necrosis (HP:0001404) | 1.76272502 |
| 167 | Erythroderma (HP:0001019) | 1.75214509 |
| 168 | Myositis (HP:0100614) | 1.74461387 |
| 169 | Abnormality of the corticospinal tract (HP:0002492) | 1.70487822 |
| 170 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 1.70399558 |
| 171 | Hepatic necrosis (HP:0002605) | 1.70134924 |
| 172 | Hyperbilirubinemia (HP:0002904) | 1.69991967 |
| 173 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 1.69188260 |
| 174 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.67898834 |
| 175 | Abnormality of the lumbar spine (HP:0100712) | 1.66789991 |
| 176 | Abnormality of the axillary hair (HP:0100134) | 1.64916208 |
| 177 | Abnormality of secondary sexual hair (HP:0009888) | 1.64916208 |
| 178 | Increased IgM level (HP:0003496) | 1.64722452 |
| 179 | Abnormality of T cell number (HP:0011839) | 1.63711159 |
| 180 | Abnormality of iron homeostasis (HP:0011031) | 1.62945084 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PBK | 3.80016368 |
| 2 | MST4 | 3.20631825 |
| 3 | STK39 | 2.98284884 |
| 4 | EIF2AK3 | 2.91024845 |
| 5 | CASK | 2.89429648 |
| 6 | OXSR1 | 2.73778799 |
| 7 | MAP3K14 | 2.67121695 |
| 8 | FRK | 2.56428184 |
| 9 | BLK | 2.21742990 |
| 10 | GRK7 | 2.14672636 |
| 11 | TXK | 2.09221792 |
| 12 | EPHB1 | 2.05492040 |
| 13 | BMPR2 | 2.03159206 |
| 14 | RIPK4 | 2.01046386 |
| 15 | CAMKK2 | 1.94799629 |
| 16 | GRK6 | 1.75138065 |
| 17 | IKBKE | 1.63433738 |
| 18 | FGR | 1.62641246 |
| 19 | BCR | 1.59891840 |
| 20 | TBK1 | 1.50591568 |
| 21 | IRAK4 | 1.44624567 |
| 22 | TNIK | 1.42251622 |
| 23 | CDK19 | 1.40302349 |
| 24 | TYK2 | 1.38759575 |
| 25 | MAP3K12 | 1.37026518 |
| 26 | JAK3 | 1.36446510 |
| 27 | MUSK | 1.35781539 |
| 28 | MAPKAPK5 | 1.35591016 |
| 29 | ACVR1B | 1.34513466 |
| 30 | BMPR1B | 1.33881396 |
| 31 | MARK3 | 1.29765000 |
| 32 | ITK | 1.26737443 |
| 33 | EPHA3 | 1.26358309 |
| 34 | BRD4 | 1.23335134 |
| 35 | HCK | 1.23312567 |
| 36 | PKN1 | 1.20754450 |
| 37 | TEC | 1.18019679 |
| 38 | IKBKB | 1.17090504 |
| 39 | MAP3K13 | 1.16935090 |
| 40 | IRAK3 | 1.14226203 |
| 41 | FGFR3 | 1.09961047 |
| 42 | PIK3CA | 1.09521174 |
| 43 | PRKCQ | 1.08397416 |
| 44 | TAOK3 | 1.06934853 |
| 45 | MET | 1.06840419 |
| 46 | ARAF | 1.04609428 |
| 47 | ADRBK2 | 1.02621411 |
| 48 | PIM1 | 1.00124769 |
| 49 | MST1R | 1.00089160 |
| 50 | ERBB4 | 0.99246629 |
| 51 | MAP4K1 | 0.98732740 |
| 52 | STK10 | 0.96177138 |
| 53 | STK24 | 0.94850887 |
| 54 | CLK1 | 0.94077540 |
| 55 | LCK | 0.93040779 |
| 56 | MAP2K7 | 0.92144816 |
| 57 | KIT | 0.91708165 |
| 58 | MOS | 0.89871084 |
| 59 | NUAK1 | 0.87091532 |
| 60 | CDK6 | 0.86790013 |
| 61 | SYK | 0.86694472 |
| 62 | TGFBR2 | 0.85731303 |
| 63 | SIK3 | 0.85225282 |
| 64 | CSK | 0.84081998 |
| 65 | STK38L | 0.83499720 |
| 66 | LYN | 0.83115222 |
| 67 | CAMK2B | 0.81081258 |
| 68 | ABL2 | 0.80920470 |
| 69 | MAP3K3 | 0.80445895 |
| 70 | MAPK11 | 0.80416012 |
| 71 | SGK494 | 0.80129538 |
| 72 | SGK223 | 0.80129538 |
| 73 | NEK6 | 0.79785883 |
| 74 | GRK1 | 0.79695001 |
| 75 | BRSK2 | 0.77903091 |
| 76 | GRK5 | 0.77597880 |
| 77 | ERBB3 | 0.75833827 |
| 78 | FES | 0.74489555 |
| 79 | MAPK15 | 0.72768548 |
| 80 | PIM2 | 0.71489084 |
| 81 | FGFR4 | 0.69796312 |
| 82 | TRPM7 | 0.69487470 |
| 83 | CAMK2G | 0.69149045 |
| 84 | JAK1 | 0.68606383 |
| 85 | CAMK2A | 0.68388731 |
| 86 | STK16 | 0.66424401 |
| 87 | MAP4K2 | 0.66116424 |
| 88 | EIF2AK1 | 0.65682523 |
| 89 | MYLK | 0.65596637 |
| 90 | BTK | 0.65463261 |
| 91 | EPHA4 | 0.64783013 |
| 92 | MAP3K2 | 0.62927795 |
| 93 | PLK2 | 0.62827354 |
| 94 | ZAK | 0.62822447 |
| 95 | IRAK1 | 0.61892206 |
| 96 | PRKCE | 0.61652628 |
| 97 | DAPK2 | 0.59954030 |
| 98 | PRKCD | 0.59144927 |
| 99 | PRPF4B | 0.58362394 |
| 100 | MATK | 0.57271039 |
| 101 | CCNB1 | 0.57202375 |
| 102 | PDK1 | 0.56911584 |
| 103 | NME1 | 0.56807670 |
| 104 | CAMK2D | 0.56626091 |
| 105 | MAP2K4 | 0.56170062 |
| 106 | NLK | 0.55741509 |
| 107 | CSF1R | 0.55510243 |
| 108 | CSNK1G3 | 0.54592932 |
| 109 | SCYL2 | 0.53237860 |
| 110 | JAK2 | 0.52366984 |
| 111 | MAPK7 | 0.52182486 |
| 112 | IRAK2 | 0.52134142 |
| 113 | NME2 | 0.51906740 |
| 114 | IGF1R | 0.51782658 |
| 115 | PIK3CG | 0.51432283 |
| 116 | YES1 | 0.51409087 |
| 117 | ZAP70 | 0.50012564 |
| 118 | FYN | 0.49482208 |
| 119 | ADRBK1 | 0.49201233 |
| 120 | TNK2 | 0.49154022 |
| 121 | SIK1 | 0.48292672 |
| 122 | BCKDK | 0.47908113 |
| 123 | ABL1 | 0.47355601 |
| 124 | PASK | 0.47353461 |
| 125 | CDK4 | 0.47296792 |
| 126 | ROCK2 | 0.46963108 |
| 127 | TIE1 | 0.46634710 |
| 128 | MAPK4 | 0.46047556 |
| 129 | NEK9 | 0.45978511 |
| 130 | EGFR | 0.45496647 |
| 131 | SRPK1 | 0.45117253 |
| 132 | VRK1 | 0.43021669 |
| 133 | MAP2K3 | 0.42871104 |
| 134 | CAMKK1 | 0.42001566 |
| 135 | EIF2AK2 | 0.41753829 |
| 136 | MAP2K6 | 0.38592160 |
| 137 | TLK1 | 0.37704846 |
| 138 | MAP3K5 | 0.36042490 |
| 139 | CHUK | 0.33293624 |
| 140 | RPS6KA4 | 0.33249472 |
| 141 | SGK2 | 0.32218464 |
| 142 | AKT3 | 0.31077716 |
| 143 | MKNK1 | 0.30821703 |
| 144 | RPS6KA5 | 0.28961249 |
| 145 | INSR | 0.28184944 |
| 146 | PRKAA2 | 0.26980565 |
| 147 | PDK2 | 0.26906303 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Steroid biosynthesis_Homo sapiens_hsa00100 | 3.42227019 |
| 2 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 3.22019582 |
| 3 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.99757276 |
| 4 | Fatty acid elongation_Homo sapiens_hsa00062 | 2.97484738 |
| 5 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.92855647 |
| 6 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.79003721 |
| 7 | Histidine metabolism_Homo sapiens_hsa00340 | 2.49925891 |
| 8 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.45446562 |
| 9 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.39948640 |
| 10 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.29559762 |
| 11 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.26196920 |
| 12 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.17132595 |
| 13 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.11844595 |
| 14 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 2.01931311 |
| 15 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.97809142 |
| 16 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.96730014 |
| 17 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.95738586 |
| 18 | Viral myocarditis_Homo sapiens_hsa05416 | 1.90926885 |
| 19 | Peroxisome_Homo sapiens_hsa04146 | 1.89619563 |
| 20 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.88004663 |
| 21 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.86908272 |
| 22 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.84740477 |
| 23 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.84290383 |
| 24 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.83380044 |
| 25 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.71673080 |
| 26 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.64223401 |
| 27 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.62439759 |
| 28 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.61091960 |
| 29 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.59590704 |
| 30 | Retinol metabolism_Homo sapiens_hsa00830 | 1.53677306 |
| 31 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.53410549 |
| 32 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.51043881 |
| 33 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.46819044 |
| 34 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.45501891 |
| 35 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.45359281 |
| 36 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.44641117 |
| 37 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.43064293 |
| 38 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.35504706 |
| 39 | Influenza A_Homo sapiens_hsa05164 | 1.33638641 |
| 40 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.33113279 |
| 41 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.32872141 |
| 42 | * Ether lipid metabolism_Homo sapiens_hsa00565 | 1.32200981 |
| 43 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.31399828 |
| 44 | Allograft rejection_Homo sapiens_hsa05330 | 1.25847310 |
| 45 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.25301764 |
| 46 | Protein export_Homo sapiens_hsa03060 | 1.24990887 |
| 47 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.23528454 |
| 48 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.23353194 |
| 49 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.23294227 |
| 50 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.21868221 |
| 51 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.16451410 |
| 52 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.15119936 |
| 53 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.14112701 |
| 54 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.07862671 |
| 55 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.07605214 |
| 56 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.06446918 |
| 57 | Malaria_Homo sapiens_hsa05144 | 1.03551331 |
| 58 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.01983015 |
| 59 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.00259308 |
| 60 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.99509514 |
| 61 | Phagosome_Homo sapiens_hsa04145 | 0.95947734 |
| 62 | Pertussis_Homo sapiens_hsa05133 | 0.95602024 |
| 63 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.94752049 |
| 64 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.94538394 |
| 65 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.91569315 |
| 66 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.91561431 |
| 67 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.91390878 |
| 68 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.90351556 |
| 69 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.89046329 |
| 70 | Alzheimers disease_Homo sapiens_hsa05010 | 0.88468834 |
| 71 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.86429191 |
| 72 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.85590855 |
| 73 | Parkinsons disease_Homo sapiens_hsa05012 | 0.85419534 |
| 74 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.84258526 |
| 75 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.84255251 |
| 76 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.83860064 |
| 77 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.83487886 |
| 78 | Hepatitis B_Homo sapiens_hsa05161 | 0.83274613 |
| 79 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.83059271 |
| 80 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.81391009 |
| 81 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.80809531 |
| 82 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.79379267 |
| 83 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.78167554 |
| 84 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.77882574 |
| 85 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.76389125 |
| 86 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.75930516 |
| 87 | Apoptosis_Homo sapiens_hsa04210 | 0.73128330 |
| 88 | Lysosome_Homo sapiens_hsa04142 | 0.72369451 |
| 89 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.70608796 |
| 90 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.70541005 |
| 91 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.70454903 |
| 92 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.70128052 |
| 93 | ABC transporters_Homo sapiens_hsa02010 | 0.70105187 |
| 94 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.67939009 |
| 95 | Legionellosis_Homo sapiens_hsa05134 | 0.67623733 |
| 96 | Leishmaniasis_Homo sapiens_hsa05140 | 0.66740455 |
| 97 | Platelet activation_Homo sapiens_hsa04611 | 0.66257444 |
| 98 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.65751838 |
| 99 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.64660751 |
| 100 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.64549701 |
| 101 | Other glycan degradation_Homo sapiens_hsa00511 | 0.63558100 |
| 102 | Hepatitis C_Homo sapiens_hsa05160 | 0.60935331 |
| 103 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.58865357 |
| 104 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.58558506 |
| 105 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.57915923 |
| 106 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.57873072 |
| 107 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.57682694 |
| 108 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.57532697 |
| 109 | Bile secretion_Homo sapiens_hsa04976 | 0.56848989 |
| 110 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.56017492 |
| 111 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.55292887 |
| 112 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.54367023 |
| 113 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.53706090 |
| 114 | Proteasome_Homo sapiens_hsa03050 | 0.53197645 |
| 115 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.51631461 |
| 116 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.50996797 |
| 117 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.50648789 |
| 118 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.49533044 |
| 119 | Asthma_Homo sapiens_hsa05310 | 0.47813393 |
| 120 | HTLV-I infection_Homo sapiens_hsa05166 | 0.46747490 |
| 121 | Sulfur relay system_Homo sapiens_hsa04122 | 0.45829076 |
| 122 | Salmonella infection_Homo sapiens_hsa05132 | 0.45774515 |
| 123 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.44943499 |
| 124 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.43875316 |
| 125 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.43865888 |
| 126 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.43268027 |
| 127 | Shigellosis_Homo sapiens_hsa05131 | 0.43008657 |
| 128 | RNA degradation_Homo sapiens_hsa03018 | 0.41791799 |
| 129 | Tuberculosis_Homo sapiens_hsa05152 | 0.41041211 |
| 130 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.40000481 |
| 131 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.38129436 |
| 132 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.38008093 |
| 133 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.37197718 |
| 134 | Measles_Homo sapiens_hsa05162 | 0.36388492 |
| 135 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.36140172 |
| 136 | Homologous recombination_Homo sapiens_hsa03440 | 0.34032737 |
| 137 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.33296181 |
| 138 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.32287486 |
| 139 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.27410453 |
| 140 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.26459567 |
| 141 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.26012492 |
| 142 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.25520717 |
| 143 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.21903644 |
| 144 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.21156461 |
| 145 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.20182447 |
| 146 | * Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.18278891 |
| 147 | Insulin resistance_Homo sapiens_hsa04931 | 0.14859988 |
| 148 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.12502310 |
| 149 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.12209168 |

